ARTICLE | Company News
Isis Pharmaceuticals, SQI Diagnostics deal
November 11, 2013 8:00 AM UTC
SQI will use its Ig Plex multiplexing immunogenicity technology to develop a multiplex anti-drug antibody assay for Isis. Ig Plex allows for simultaneous quantification of Ig isotype and subclass for multiple therapeutic proteins in the same test well. The companies declined to disclose further details. ...